Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Yong Hong ChenBeverly L Davidson

Abstract

Recombinant vector systems have been recently identified that when delivered systemically can transduce neurons, glia, and endothelia in the central nervous system (CNS), providing an opportunity to develop therapies for diseases affecting the brain without performing direct intracranial injections. Vector systems based on adeno-associated virus (AAV) include AAV serotype 9 (AAV9) and AAVs that have been re-engineered at the capsid level for CNS tropism. Here, we performed a head-to-head comparison of AAV9 and a capsid modified AAV for their abilities to rescue CNS and peripheral disease in an animal model of lysosomal storage disease (LSD), the mucopolysacharidoses (MPS) VII mouse. While the peptide-modified AAV reversed cognitive deficits, improved storage burden in the brain, and substantially prolonged survival, we were surprised to find that AAV9 provided no CNS benefit. Additional experiments demonstrated that sialic acid, a known inhibitor of AAV9, is elevated in the CNS of MPS VII mice. These studies highlight how disease manifestations can dramatically impact the known tropism of recombinant vectors, and raise awareness to assuming similar transduction profiles between normal and disease models.

References

Jul 17, 1998·The Journal of Clinical Investigation·D RajotteE Ruoslahti
Jan 20, 1999·Cellular and Molecular Life Sciences : CMLS·C Traving, R Schauer
Mar 29, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·W A FrisellaM S Sands
Jun 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·M GrifmanM D Weitzman
Aug 2, 2001·Current Opinion in Chemical Biology·M KoloninW Arap
Sep 21, 2001·Nucleosides, Nucleotides & Nucleic Acids·J Wölcke, E Weinhold
Feb 1, 2002·Nature Medicine·Wadih ArapRenata Pasqualini
May 9, 2002·Expert Opinion on Investigational Drugs·Emil D Kakkis
Oct 14, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gumei LiuBeverly L Davidson
Jan 3, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lorraine M WorkAndrew H Baker
Mar 21, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mark S Sands, Beverly L Davidson
Mar 21, 2006·Trends in Cardiovascular Medicine·Amin HajitouWadih Arap
Apr 21, 2006·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brian A Karolewski, John H Wolfe
Apr 24, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Maria Luisa Balestrieri, Claudio Napoli
Mar 26, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Michael ChangBeverly L Davidson
May 3, 2008·The Journal of Gene Medicine·Hildegard BüningMichael Hallek
Aug 21, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cassia N CearleyJohn H Wolfe
Dec 23, 2008·Nature Biotechnology·Kevin D FoustBrian K Kaspar
Apr 14, 2009·Experimental Neurology·Shannon L Macauley, Mark S Sands
Feb 19, 2011·The Journal of Biological Chemistry·Shen ShenAravind Asokan
Feb 19, 2011·Nature Reviews. Neuroscience·Edward A NeuweltLester R Drewes
Feb 22, 2011·The Journal of Biological Chemistry·Tomio YabeMakoto Kiso
Mar 10, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Haiyan FuDouglas M McCarty
Apr 14, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Steven J GrayR Jude Samulski
May 18, 2011·The Journal of Clinical Investigation·Christie L BellJames M Wilson
Jul 7, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Su XuPeter Lobel
Aug 4, 2011·Molecular Therapy : the Journal of the American Society of Gene Therapy·Adam K BevanBrian K Kaspar
Nov 4, 2011·Nature Reviews. Neuroscience·Berislav V Zlokovic

❮ Previous
Next ❯

Citations

Apr 24, 2013·Journal of Inherited Metabolic Disease·N Joan Abbott
Oct 15, 2014·Molecular Therapy. Nucleic Acids·James C GeogheganBeverly L Davidson
Aug 5, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Salim S El-AmouriDao Pan
Nov 26, 2015·Molecular Genetics and Metabolism·Joshua T DearbornMark S Sands
Jan 12, 2016·Expert Opinion on Emerging Drugs·Roberto GiuglianiGuilherme Baldo
Jan 24, 2014·Expert Opinion on Drug Delivery·Guilherme BaldoUrsula Matte
Dec 17, 2014·Expert Opinion on Drug Delivery·Daniel A WolfWalter C Low
Dec 30, 2014·Molecular Genetics and Metabolism·Shunji TomatsuTadao Orii
Oct 7, 2014·Frontiers in Molecular Neuroscience·Giridhar MurlidharanAravind Asokan
Jan 22, 2015·The Journal of Clinical Investigation·Randy J ChandlerCharles P Venditti
Jun 9, 2016·Human Gene Therapy·Michaël HocquemillerNathalie Cartier
Oct 9, 2015·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brittney L GurdaMark E Haskins
Aug 11, 2018·Nature Reviews. Drug Discovery·Benjamin E DevermanDinah W Y Sah
Nov 20, 2018·Journal of Human Genetics·Hiroshi Kobayashi
Nov 25, 2014·Expert Opinion on Orphan Drugs·Shunji TomatsuTadao Orii
Dec 23, 2017·Frontiers in Molecular Neuroscience·Andrew P Tosolini, James N Sleigh
Oct 12, 2018·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Danica B StanimirovicWill J Costain
Aug 9, 2020·Frontiers in Molecular Neuroscience·Andrew P Tosolini, James N Sleigh
May 7, 2019·Expert Opinion on Biological Therapy·Murtaza S NagreeJeffrey A Medin
Aug 25, 2021·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Hanna GraßhoffMarkus Schwaninger

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Molecular Therapy : the Journal of the American Society of Gene Therapy
John Forsayeth, Krystof S Bankiewicz
Proceedings of the National Academy of Sciences of the United States of America
Ha T HuynhWilliam S Sly
© 2021 Meta ULC. All rights reserved